BevCanna Significantly Expands its Cannabis Genetics Program with the Acquisition of Carmanah Craft Corp. Cannabis Investing News
Chemesis International Inc. Announces Conversion of $2,109,461 Convertible Debt to Equity Cannabis Investing News
Cardiol Therapeutics’ Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada Cannabis Investing News
Weekend Unlimited Announces Addition to Management and Change in Board Of Directors Cannabis Investing News